BIOS5130 Week 11 Part 1 Lecture Slides (1) Human anatomy ll
Disorders of the Nervous System
Overview
Disorders of the nervous system include various categories of diseases affecting neural function.
Neurodegenerative Diseases
Alzheimer's Disease
Most common cause of dementia; affects ~0.5-0.6% of the global population (approximately 50 million people).
Incidence increases with age: 7-10% for those over 65, 40% for those over 80.
Symptoms include cognitive impairment, memory loss, and disorientation.
Pathology includes neurofibrillary tangles and amyloid plaques leading to neuronal degeneration.
Parkinson's Disease
Second most common neurodegenerative disease, affecting 0.2% of the world's population.
Characterized by tremors, rigidity, and motion difficulties due to dopaminergic neuron degeneration.
Age is the biggest risk factor; most cases arise after 50.
Demyelinating Diseases
Multiple Sclerosis (MS)
Affects ~2.5 million people globally, with lesions in CNS myelin leading to motor and sensory defects.
Can be classified into four types:
Relapsing-Remitting (RRMS) - alternating periods of recovery and relapse.
Secondary Progressive (SPMS) - gradual deterioration post-RRMS.
Primary Progressive (PPMS) - steadily progressive without remissions.
Progressive Relapsing (PRMS) - progressive deterioration during relapse phases.
Guillain-Barré Syndrome
Rare autoimmune condition triggered by infections, attacking Schwann cell myelin, leading to paralysis.
Charcot-Marie-Tooth Disease
Inherited peripheral neuropathy, impacting motor and sensory nerves, with a prevalence of 1 in 2500.
Impact of Neurodegenerative Diseases
Mortality Rates
Death rates from Alzheimer’s disease more than doubled between 2000 and 2019, becoming a leading cause of death in high-income countries.
In the UK, Alzheimer’s and dementia are now the leading causes of death for females.
Measure of Disease Burden
Disability-Adjusted Life Years (DALYs)
DALY Calculation = YLL (Years of Life Lost) + YLD (Years Lived with Disability)
1 DALY represents 1 year of full health lost.
Neurological conditions accounted for a significant DALYs burden, particularly Alzheimer's and other dementias.
Causes and Risk Factors
Alzheimer's Disease
Major risk factors include age, genetic mutations (e.g., in APP and presenilin genes), and environmental factors (e.g., aluminum exposure).
Late-onset and early-onset Alzheimer’s can be influenced by different genetic and environmental components.
Parkinson’s Disease
Genetic factors play a significant role, including SNCA gene mutation related to alpha-synuclein.
Environmental factors may exacerbate the condition.
Treatments
Current Treatments
Alzheimer's Disease:
Acetylcholinesterase inhibitors (e.g., donepezil) to alleviate symptoms.
Memantine to regulate glutamate and protect neurons.
Parkinson’s Disease:
L-DOPA to increase dopamine levels.
Surgical options like Deep Brain Stimulation and emerging therapies such as cell replacement.
MS Treatments
Diagnosis includes neurological exams and MRI; treated with β-interferons and monoclonal antibodies to reduce inflammation.
Summary of Learning Outcomes
Understand prevalence and burden of these diseases.
Distinguish categories of diseases, symptoms, affected regions, and types of nervous systems involved (CNS or PNS).
Identify current and possible future treatments and their mechanisms.